Abstract

An intronic expansion (AAGGG)exp in the RFC1 gene has recently been shown to cause recessively inherited cerebellar ataxia, neuropathy, and vestibular areflexia syndrome and, furthermore, a few patients with ataxia and parkinsonism have been reported. We investigated 569 Finnish patients with medicated parkinsonism for RFC1 and found biallelic (AAGGG)exp in three non-consanguineous patients with clinically confirmed Parkinson’s disease without ataxia suggesting that RFC1-related disorders include Parkinson’s disease as well.

Highlights

  • The replication factor C complex is a five-subunit ATPase required for DNA replication and repair

  • We report on screening of a population-based cohort of Finnish patients with medicated parkinsonism for RFC1 (AAGGG)exp

  • We found nine subjects with the homozygous (AAGGG)expassociated core haplotype among 569 patients with medicated parkinsonism (Supplementary Table 1) and two out of 269 controls

Read more

Summary

Introduction

The replication factor C complex is a five-subunit ATPase required for DNA replication and repair. We report on screening of a population-based cohort of Finnish patients with medicated parkinsonism for RFC1 (AAGGG)exp. We found nine subjects with the homozygous (AAGGG)expassociated core haplotype among 569 patients with medicated parkinsonism (Supplementary Table 1) and two out of 269 controls. But three of the 9 patients, harbored biallelic (AAGGG)exp in RFC1 (Fig. 1).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.